GNNSF logo
Genscript Biotech Corporation(GNNSF)
Closing price · checked 10:35 PM ETAbout this dataData status
$3.53▼-0.25 (-6.61%)
Extended:$3.78+0.25 (+7.08%)· 10:35 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Genscript Biotech Corporation (GNNSF)

Total Current Liabilities

$726.58M

Quarterly · Period ending: · USD

GNNSF logo

GNNSF Total Current Liabilities

Latest reported$720.08M
GNNSF FY Current Liabilities ($29.89M → $720.08M)
High-resolution chart · PNG

What is total current liabilities?

Liabilities due within one year.

GNNSF total current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Genscript Biotech Corporation Total Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Current Liabilities (USD)Change
720,075,232+134.29%
307,342,000−37.89%
494,811,000−9.37%
545,978,000+17.57%
464,367,000+41.61%
327,911,000+46.06%
224,505,000+46.24%
153,515,000−43.71%
272,716,000+595.44%
39,215,000+26.93%
30,894,000+5.84%
29,188,000−2.33%
29,885,000—

Frequently asked questions: GNNSF total current liabilities

What is Genscript Biotech Corporation (GNNSF)'s current total current liabilities?

Genscript Biotech Corporation (GNNSF)'s latest reported total current liabilities (Quarterly) is $726.58M as of Jun 30, 2026. Liabilities due within one year.

How much historical total current liabilities data is available for GNNSF?

Stock Alarm Pro provides 13 dated annual fiscal periods observations for Genscript Biotech Corporation (GNNSF)'s total current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare GNNSF's total current liabilities to peers or set an alert?

You can open GNNSF's total current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GNNSF delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.